ARCHIVES

FDA cancer therapeutics review split among three units in reorganization.

This article is from The Cancer Letter archive.

Vol. 29 No. 37 | October 10, 2003

Download PDF Visit The Full Archive

Related Articles

Abstracts Of Papers Presented By Breast Cancer Task Force

July 16, 1976

Phase III Trial of ThermoDox Fails to Meet Primary Endpoint

February 22, 2013

Gritz is president-elect of Society for Research on Nicotine and Tobacco.

September 23, 2005

House May Add $80 Million To NCI Budget For FY 1984

September 16, 1983

Samuel Waksal Pleads Guilty To Tax Evasion

March 7, 2003

Cancer Groups Support Senate FDA Bill; Reform Measure Face Uncertain future

March 1, 1996